Subscribe to RSS
DOI: 10.5999/aps.2015.42.5.544
Comparative Analysis of the Extracellular Matrix Composition in Proliferating and Involuted Infantile Hemangiomas
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education (2014R1A1A4A01009584).
Background Changes in the composition of the extracellular matrix (ECM) occur between the proliferating and involuted phases of infantile hemangiomas (IH), and are associated with angiogenic growth. We examined the composition of the ECM in proliferating and involuted IHs and assessed correlations between the composition of the ECM and whether the IH was in the proliferating or the involuted phase.
Methods We evaluated IH samples from a cohort of patients who had five proliferating IHs and five involuted IHs. The following ECM molecules were analyzed using enzyme-linked immunosorbent assays and immunohistochemistry: laminin, fibronectin, collagen type I, collagen type II, and collagen type III.
Results The involuted IHs had higher levels of deposition of collagen type III than the proliferating IHs. The median values (interquartile ranges) were 1.135 (0.946-1.486) and 1.008 (0.780-1.166) (P=0.019), respectively. The level of laminin was higher in involuted IHs than in proliferating IHs, with median values (interquartile ranges) of 3.191 (2.945-3.191) and 2.479 (1.699-3.284) (P=0.047), respectively. Abundant collagen type III staining was found in involuted IHs. Laminin α4 chain staining was clearly present within the basement membrane adjacent to the blood vessels, and was significantly more intense in involuted IHs than in proliferative IHs.
Conclusions Involuted hemangiomas showed extensive deposition of collagen III and laminin, suggesting that differences in the composition of the ECM reflect stages of the development of IHs. This pattern may be due to the rapid senescence of IHs.
This article was presented at the 5th R&R Forum on May 14, 2015 in Pyeongchang, Korea.
Publication History
Received: 16 April 2015
Accepted: 23 July 2015
Article published online:
05 May 2022
© 2015. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Kleiman A, Keats EC, Chan NG. et al. Evolution of hemangioma endothelium. Exp Mol Pathol 2012; 93: 264-272
- 2 Szychta P, Stewart K, Anderson W. Treatment of infantile hemangiomas with propranolol: clinical guidelines. Plast Reconstr Surg 2014; 133: 852-862
- 3 Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20 (Suppl. 01) 678-684
- 4 Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009; 12: 197-207
- 5 Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005; 97: 1093-1107
- 6 Jang YC, Arumugam S, Ferguson M. et al. Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res 1998; 80: 9-15
- 7 Yu Y, Fuhr J, Boye E. et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006; 24: 1605-1612
- 8 Rhodes JM, Simons M. The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med 2007; 11: 176-205
- 9 Mohammadzadeh E, Nikravesh MR, Jalali M. et al. Immunohistochemical study of type III collagen expression during pre and post-natal rat skin morphogenesis. Iran J Basic Med Sci 2014; 17: 196-200
- 10 Jensen LT, Host NB. Collagen: scaffold for repair or execution. Cardiovasc Res 1997; 33: 535-539
- 11 Labat-Robert J, Kern P, Robert L. Biomarkers of connective tissue aging: biosynthesis of fibronectin, collagen type III, and elastase. Ann N Y Acad Sci 1992; 673: 16-22
- 12 Antia M, Baneyx G, Kubow KE. et al. Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss 2008; 139: 229-249
- 13 Lemanska-Perek A, Pupek M, Polanska B. et al. Alterations in molecular status of plasma fibronectin associated with aging of normal human individuals. Clin Biochem 2013; 46: 787-794
- 14 Hallmann R, Horn N, Selg M. et al. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005; 85: 979-1000
- 15 Eble JA, Niland S. The extracellular matrix of blood vessels. Curr Pharm Des 2009; 15: 1385-1400
- 16 Matz RL, Schott C, Stoclet JC. et al. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 2000; 49: 11-18
- 17 Ferlosio A, Arcuri G, Doldo E. et al. Age-related increase of stem marker expression influences vascular smooth muscle cell properties. Atherosclerosis 2012; 224: 51-57
- 18 Scioli MG, Bielli A, Arcuri G. et al. Ageing and microvasculature. Vasc Cell 2014; 6: 19
- 19 Feihl F, Liaudet L, Levy BI. et al. Hypertension and microvascular remodelling. Cardiovasc Res 2008; 78: 274-285
- 20 Hughes S, Gardiner T, Hu P. et al. Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability. Neurobiol Aging 2006; 27: 1838-1847
- 21 Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66: 286-294
- 22 Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274